ROYALTY PHARMA PLC shareholders Q3 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
S&CO INC 253,610$6,8820.56%
Beck Bode, LLC 72,578$1,969,7760.50%
Eventide Asset Management 1,004,146$27,252,5220.49%
Ridgewood Investments LLC 25,787$699,8620.46%
Baillie Gifford 18,241,284$495,068,4480.45%
Rhenman & Partners Asset Management AB 150,000$4,071,0000.44%
Eaton Financial Holdings Company, LLC 53,349$1,447,8830.39%
PDT Partners, LLC 108,459$2,943,5770.37%
OSTRUM ASSET MANAGEMENT 140,265$3,806,7920.35%
PACK Private Wealth, LLC 17,414$466,8690.35%
Headlands Technologies LLC 23,578$639,9070.32%
EVERGREEN CAPITAL MANAGEMENT LLC 248,402$6,741,6390.30%
Pearl River Capital, LLC 68,519$1,859,6060.29%
Cipher Capital LP 14,133$383,5700.27%
abrdn plc 3,705,669$100,571,8570.26%
Andra AP-fonden 158,200$4,293,5480.25%
Formidable Asset Management, LLC 41,546$1,116,2840.25%
WORLDQUANT MILLENNIUM ADVISORS LLC 576,904$15,657,1750.24%
Alyeska Investment Group, L.P. 1,228,245$33,334,5690.23%
Seaport Global Advisors, LLC 2,651$71,9480.22%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q3 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.